This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bryant, S. G. Articles by Felthous, A. R. Search for Related Content Social Bookmarking                         What's this?

Antipsychotic Drugs: Medicolegal Implications for Pharmacists

University of Texas Medical Branch, Galveston, TX77550

Linda Ann Felthous

From the Department of Psychiatry and Behavioral Sciences, The University of Texas Medical Branch at Galveston; Private Law Practice, Seattle, Washington, Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch at Galveston, Galveston, TX.

Alan R. Felthous

From the Department of Psychiatry and Behavioral Sciences, The University of Texas Medical Branch at Galveston; Private Law Practice, Seattle, Washington, Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch at Galveston, Galveston, TX.

The purposes of this article are to briefly review the adverse reactions induced by antipsychotics that have the greatest modicolegal implications and to set them in the context of pharmacist liability for patient injury. Although little or no case law has evolved specifying antipsychotic drugs and the pharmacist's possible duty to warn, such an obligation may be increasingly realized as standards of practice in psychiatric pharmacy are elevated.

Journal of Pharmacy Practice, Vol. 3, No. 4, 276-280 (1990)
DOI: 10.1177/089719009000300409


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?